Stemtech Corporation
STEK · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $852 | $698 | $868 | $1,314 |
| % Growth | 22.1% | -19.6% | -33.9% | – |
| Cost of Goods Sold | $170 | $146 | $148 | $269 |
| Gross Profit | $682 | $552 | $720 | $1,045 |
| % Margin | 80.1% | 79.1% | 83% | 79.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $882 | $698 | $1,727 | $1,090 |
| SG&A Expenses | $897 | $732 | $1,740 | $924 |
| Sales & Mktg Exp. | $14 | $34 | $12 | -$166 |
| Other Operating Expenses | $0 | $121 | $186 | $88 |
| Operating Expenses | $897 | $853 | $1,925 | $1,012 |
| Operating Income | -$214 | -$301 | -$1,205 | $33 |
| % Margin | -25.1% | -43.1% | -138.8% | 2.5% |
| Other Income/Exp. Net | -$599 | $5 | -$254 | -$430 |
| Pre-Tax Income | -$813 | -$296 | -$1,459 | -$397 |
| Tax Expense | -$809 | $0 | $0 | $0 |
| Net Income | -$3 | -$293 | -$1,456 | -$397 |
| % Margin | -0.4% | -42% | -167.7% | -30.2% |
| EPS | -0.01 | -0.002 | -0.01 | -0.003 |
| % Growth | -376.2% | 79% | -244.8% | – |
| EPS Diluted | -0.01 | -0.002 | -0.01 | -0.003 |
| Weighted Avg Shares Out | 150,103 | 142,443 | 118,698 | 118,698 |
| Weighted Avg Shares Out Dil | 150,103 | 142,443 | 118,698 | 118,698 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | -$509 | $80 | $245 | $538 |
| Depreciation & Amortization | $0 | $42 | $42 | $16 |
| EBITDA | -$214 | -$175 | -$1,171 | $157 |
| % Margin | -25.1% | -25% | -135% | 11.9% |